Shijie Yang

Shijie Yang

Auto-generated profile, based on publicly available information

Shijie Yang

Department of Emergency, Beijing Anzhen Hospital, Capital Medical University, 100029 Beijing, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2023 in The Journal of Clinical Hypertension
Verified
Journal Article
Open access
SYShijie Yang
Shijie Yang
ZZZhanyang Zhou
Zhanyang Zhou
HMHuanhuan Miao
Huanhuan Miao
YZYuqing Zhang
Yuqing Zhang
To determine quantitative differences between weight loss and changes in clinic blood pressure (BP) and ambulatory BP in patients with obesity or overweight, the authors performed a meta‐analysis. PubMed, Embase, and Scopus databases were searched up to June 2022. Studies that compared clinic or ambulatory BP with weight loss were included. A random effect model was applied to pool the differences between clinic BP and ambulatory BP. Thirty‐five studies, for a total of 3219 patients were included in this meta‐analysis. The clinic systolic blood pressure (SBP) and diastolic blood pressure (DBP) were significantly reduced by 5.79 mmHg (95% CI, 3.54–8.05) and 3.36 mmHg (95% CI, 1.93–4.75) after a mean body mass index (BMI) reduction of 2.27 kg/m2, and the SBP and DBP were significantly reduced by 6.65 mmHg (95% CI, 5.16–8.14) and 3.63 mmHg (95% CI, 2.03–5.24) after a mean BMI reduction of 4.12 kg/m2. The BP reductions were much larger in patients with a BMI decrease ≥3 kg/m2 than in patients with less BMI decrease, both for clinic SBP [8.54 mmHg (95% CI, 4.62–12.47)] versus [3.83 mmHg (95% CI, 1.22–6.45)] and clinic DBP [3.45 mmHg (95% CI, 1.59–5.30)] versus [3.15 mmHg (95% CI, 1.21–5.10)]. The significant reduction of the clinic and ambulatory BP followed the weight loss, and this phenomenon could be more notable after medical intervention and a larger weight loss.

24 October 2024 in The Journal of Clinical Hypertension
Verified
Journal Article
Open access
SYShijie Yang
Shijie Yang
YZYuqing Zhang
Yuqing Zhang
ZZZhanyang Zhou
Zhanyang Zhou
XDXiaochun Duan
Xiaochun Duan
The objective of this study was to investigate the association between triglyceride to high‐density lipoprotein cholesterol ratio (TG/HDL‐c), triglyceride‐glucose index (TyG), and related parameters (TyG‐BMI, TyG‐WC) with prehypertension and hypertension over 45 years old. According to the blood pressure diagnosis, the enrolled individuals were divided into two groups, which were prehypertension and hypertension. In multivariate logistic regression analysis, after adjusting for confounders, the highest quartile groups of TG/HDL‐c, TyG, and related parameters showed a significantly increased risk of hypertension compared to the lowest quartile groups, and there was associated with hypertension when comparing the highest TG/HDL‐c to the lowest TG/HDL‐c and corresponding ORs were 1.416 (1.234, 1.625) and 1.029 (0.893, 1.187), respectively. Furthermore, when comparing the fourth quartile to the first quartile of TG/HDL‐c, TyG index, and related parameters, respectively, both corresponding ORs of hypertension were higher than prehypertension. Elevated TyG, TyG‐BMI, TyG‐WC index, and TG/HDL‐c ratio levels were associated with hypertension in individuals over 45 years. Moreover, the receiver operating characteristic curve was used to compare the predictive ability of each parameter in identifying people with hypertension suggested that the TyG‐WC index ([Area under the curve] AUC: 0.601 [CI: 0.588–0.615]), TyG‐BMI, and TyG were more significant than TG/HDL‐c in distinguishing hypertension. However, in the prehypertension population, the area under the ROC curve for TyG‐BMI (0.543 [CI: 0.530–0.556]) was better than that of other parameters. They have the potential to become cost‐effective monitors in the hierarchical management of hypertension.

23 June 2025 in The Journal of Clinical Hypertension
Verified
Journal Article
Open access
SYShijie Yang
Shijie Yang
ZZZhanyang Zhou
Zhanyang Zhou
HMHuanhuan Miao
Huanhuan Miao
ZYZhen Yin
Zhen Yin
XDXiaochun Duan
Xiaochun Duan
YZYuqing Zhang
Yuqing Zhang
Accurate blood pressure measurement is fundamental for the diagnosis and management of hypertension. The emergence of u‐AOBP has been proposed as a potential alternative or complementary approach for assessing patients’ blood pressure status within clinical settings. However, robust evidence is lacking to determine its application in diagnosing hypertension within the clinical practice in China. The study involved participants recruited from October 2023 to February 2024 at three different hospitals. Participants were provided with comprehensive study information, and informed consent was obtained. Standardized, validated upper arm blood pressure monitors were used to measure blood pressure. Baseline demographic data, anthropometric measurements, u‐AOBP, and standard office blood pressure data were collected, along with additional examination results, including echocardiograms and 24‐h ambulatory blood pressure monitoring. The optimal cutoff values for diagnosing elevated blood pressure using u—AOBP, determined by ROC curve analysis with the awake ambulatory blood pressure threshold of 135/85 mmHg as the gold standard, were 130.75/83.75 mmHg (sensitivity 89.73%, specificity 27.27%). In participants with a dipper blood pressure diurnal rhythm, there was no statistically significant difference between standard office blood pressure and u‐AOBP measurements (p > 0.05). In conclusion, unattended automated office blood pressure measurement with the optimal cut‐off values for diagnosing elevated blood pressure being 130.75/83.75 mmHg, and in the population with a normal dipper circadian rhythm, the standardized u‐AOBP values can be equivalent to standard office blood pressure, but the low specificity of u‐AOBP may affect the accuracy of identifying nonhypertensive individuals.

22 April 2024 in The Journal of Clinical Hypertension
Verified
Journal Article
Open access
SYShijie Yang
Shijie Yang
ZZZhanyang Zhou
Zhanyang Zhou
HMHuanhuan Miao
Huanhuan Miao
QZQiong Zhou
Qiong Zhou
MZMei Zhai
Mei Zhai
YZYuqing Zhang
Yuqing Zhang
The aim of this study was to evaluate the accuracy of the single upper‐arm cuff oscillometric blood pressure (BP) monitor RBP‐9801 developed for office and home BP measurement in the general population according to the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO) Universal Standard (ISO 81060–2:2018). Subjects were recruited to fulfil the age, gender, BP and cuff distribution criteria of the AAMI/ESH/ISO Universal Standard in general population using the same arm sequential BP measurement method. A total of 105 subjects were recruited and 85 were analyzed. For validation criterion 1, the mean ± SD of the differences between the test device and reference BP readings was 2.3 ± 6.4/3.1 ± 5.8 mmHg (systolic/diastolic). For criterion 2, the SD of the mean BP differences between the test device and reference BP per subject was 5.24/5.03 mmHg (systolic/diastolic). The conclusion is that the RBP‐9801 oscillometric device for office and home BP measurement fulfilled all the requirements of the AAMI/ESH/ISO Universal Standard (ISO 81060–2:2018) in the general population and can be recommended for clinic and self‐use at home.

28 September 2024 in The Journal of Clinical Hypertension
Verified
Journal Article
Open access
ZZZhanyang Zhou
Zhanyang Zhou
HMHuanhuan Miao
Huanhuan Miao
SYShijie Yang
Shijie Yang
ZYZheng Yin
Zheng Yin
YCYingjun Chen
Yingjun Chen
YZYuqing Zhang
Yuqing Zhang
Recent studies indicate that intensive blood pressure (BP) targets can be reached with less than two medications. This cross‐sectional study, involving 4991 individuals from the Majiapu community, assessed the correlation between BP control and the burden of antihypertensive drugs. Participants on medication were categorized into controlled (BP < 140/90 mm Hg) and uncontrolled (BP ≥ 140/90 mm Hg) groups, with the former further divided into optimal (BP < 130/80 mm Hg) and good control (BP < 140/90 but >130/80 mm Hg) subgroups. Multivariate logistic regression analyzed factors affecting hypertension control across these BP categories. The study found that, 54% of participants had hypertension. Of those treated (62.5%), 55.7% achieved BP control, including 23.15% maintaining BP below 130/80 mm Hg. The average number of antihypertensive medications was 1.61 for the controlled group (with an average BP of 126.6/76 mm Hg) and 1.75 for the uncontrolled group (with an average BP of 150.6/84.0 mm Hg). Additionally, the average number of antihypertensive medications was 1.66 in the good control group and 1.55 in the optimal control group. The uncontrolled group had a higher mean systematic coronary risk estimation (SCORE) of 5.59, against 3.97 and 2.5 in the good and optimal control groups, respectively. Key factors linked to poor BP control included age over 65, male sex, obesity, and former smoking, whereas lipid‐lowering medication use was associated with better control. In conclusions, patients needing fewer antihypertensive drugs to achieve stricter targets may have a lower risk profile. Notably, only a small proportion of treated patients are low‐risk individuals who can easily achieve BP levels below 130/80 mm Hg.

27 November 2025 in Reviews in Cardiovascular Medicine
Verified
Journal Article
Open access
GYGeng Yang
Geng Yang
LFLong Feng
Long Feng
YPYilin Pan
Yilin Pan
MXMankun Xin
Mankun Xin
WDWenwen Duan
Wenwen Duan
XHXiaonan He
Xiaonan He
Background: Previous studies on acute myocardial infarction (AMI) complicated by atrial fibrillation (AF) have mainly focused on anatomy or underlying disease state, and its prognostic predictors have not been fully explored. Therefore, there is a need for an effective prognosis model for patients with AMI-AF. Methods: We retrospectively selected 126 patients with acute myocardial infarction complicated with AF hospitalized in Beijing Anzhen Hospital from January 2020 to December 2024 as the case group, and 1719 patients without AF as the control group. The clinical characteristics and laboratory test results of the two groups were compared to determine independent risk factors for AF in patients with acute myocardial infarction. The predictive performance of the model was evaluated by plotting Receiver Operating Characteristic (ROC) for each independent predictor. For the combined model, we used R software to build pattern plots, calibration plots, and Decision Curve Analysis (DCA) based on a multivariate logistic regression model. Results: Multivariate Logistic regression analysis showed that older age (Odds Ratio (OR) = 1.067, 95% CI: 1.044–1.092), longer hospitalization days (OR = 1.039, 95% CI: 1.013–1.066). The AUCs for age, hospitalization days, history of coronary heart disease, heart rate, International Normalized Ratio (INR), Hemoglobin, and mean platelet volume were 0.721, 0.663, 0.577, 0.614, 0.688, 0.438, and 0.607. The AUC of nomogram model for predicting AF in AMI patients was 0.833 (95% CI: 0.796–0.870, p < 0.001), the sensitivity was 0.817, and the specificity was 0.726. The nomogram model indicated a clinical net benefit when the predicted risk threshold exceeded 0.06. Conclusions: Multivariable prediction model has good prediction effect. The variables in this nomogram model are easily obtained in clinical practice and can provide reference for individualized prediction of AF in AMI patients.